Interactions of actinomycin D with human telomeric G-quadruplex DNA.

Applications of isothermal titration calorimetry in biophysical studies of G-quadruplexes. Int J Mol Sci (2009) 0.97

Thermodynamic fingerprints of ligand binding to human telomeric G-quadruplexes. Nucleic Acids Res (2015) 0.78

In silico identification of novel ligands for G-quadruplex in the c-MYC promoter. J Comput Aided Mol Des (2014) 0.75

Selective recognition and stabilization of new ligands targeting the potassium form of the human telomeric G-quadruplex DNA. Sci Rep (2016) 0.75

Characterization of regulatory sequences in alternative promoters of hypermethylated genes associated with tumor resistance to cisplatin. Mol Clin Oncol (2014) 0.75

Switching and signaling at the telomere. Cell (2001) 11.25

Crystal structure of parallel quadruplexes from human telomeric DNA. Nature (2002) 8.90

Quadruplex DNA: sequence, topology and structure. Nucleic Acids Res (2006) 6.42

Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-tetraplex. Structure (1993) 6.05

G-quadruplexes in promoters throughout the human genome. Nucleic Acids Res (2006) 5.84

Highly prevalent putative quadruplex sequence motifs in human DNA. Nucleic Acids Res (2005) 5.34

Telomeric DNA oligonucleotides form novel intramolecular structures containing guanine-guanine base pairs. Cell (1987) 4.85

Telomeres and their control. Annu Rev Genet (2000) 4.74

Human telomeric sequence forms a hybrid-type intramolecular G-quadruplex structure with mixed parallel/antiparallel strands in potassium solution. Nucleic Acids Res (2006) 3.87

Dynamic roles for G4 DNA in the biology of eukaryotic cells. Nat Struct Mol Biol (2006) 3.35

Studies of the binding of actinomycin and related compounds to DNA. J Mol Biol (1968) 3.35

Structure and stability of human telomeric sequence. J Biol Chem (1994) 2.86

Stability and kinetics of G-quadruplex structures. Nucleic Acids Res (2008) 2.75

Inhibition of human telomerase by a G-quadruplex-interactive compound. J Med Chem (1997) 2.66

Conserved elements with potential to form polymorphic G-quadruplex structures in the first intron of human genes. Nucleic Acids Res (2008) 2.27

A hitchhiker's guide to G-quadruplex ligands. Org Biomol Chem (2007) 2.27

Circular dichroism of quadruplex DNAs: applications to structure, cation effects and ligand binding. Methods (2007) 1.99

G-quadruplex DNA: a potential target for anti-cancer drug design. Trends Pharmacol Sci (2000) 1.94

Monovalent cation induced structural transitions in telomeric DNAs: G-DNA folding intermediates. Biochemistry (1991) 1.93

Natural and pharmacological regulation of telomerase. Nucleic Acids Res (2002) 1.92

Selective interactions of cationic porphyrins with G-quadruplex structures. J Am Chem Soc (2001) 1.91

Polymorphism of human telomeric quadruplex structures. Biochimie (2008) 1.89

Telomestatin and diseleno sapphyrin bind selectively to two different forms of the human telomeric G-quadruplex structure. J Am Chem Soc (2005) 1.87

Structure of the intramolecular human telomeric G-quadruplex in potassium solution: a novel adenine triple formation. Nucleic Acids Res (2007) 1.72

Secondary DNA structures as molecular targets for cancer therapeutics. Biochem Soc Trans (2001) 1.56

ACTINOMYCIN BINDING TO DNA: MECHANISM AND SPECIFICITY. J Mol Biol (1965) 1.46

Accelerated assembly of G-quadruplex structures by a small molecule. Biochemistry (1999) 1.36

Energetics and kinetics of a conformational switch in G-quadruplex DNA. J Phys Chem B (2009) 1.29

Structure of the first parallel DNA quadruplex-drug complex. J Am Chem Soc (2003) 1.26

Sequence occurrence and structural uniqueness of a G-quadruplex in the human c-kit promoter. Nucleic Acids Res (2007) 1.24

Biophysical studies of the c-MYC NHE III1 promoter: model quadruplex interactions with a cationic porphyrin. Biophys J (2006) 1.20

Quadruplex DNA crystal structures and drug design. Biochimie (2008) 1.15

Actinomycin D binding to single-stranded DNA: sequence specificity and hemi-intercalation model from fluorescence and 1H NMR spectroscopy. J Mol Biol (1996) 1.11

Biophysical characterization of the human telomeric (TTAGGG)4 repeat in a potassium solution. Biochemistry (2007) 1.11

Binding of actinomycin D to DNA: evidence for a nonclassical high-affinity binding mode that does not require GpC sites. Proc Natl Acad Sci U S A (1989) 1.10

Binding of actinomycin D to the T(G)nT motif of double-stranded DNA: determination of the guanine requirement in nonclassical, non-GpC binding sites. Biochemistry (1994) 1.01

Calorimetric techniques in the study of high-order DNA-drug interactions. Methods Enzymol (2001) 0.89

Influence of DNA base sequence on the binding energetics of actinomycin D. Biochemistry (1993) 0.89

The circular dichroism of actinomycin D and its complexes with DNA and dGMP5'. Arch Biochem Biophys (1969) 0.85

Crystal and solution structures of 7-amino-actinomycin D complexes with d(TTAGBrUT), d(TTAGTT) and d(TTTAGTTT). Acta Crystallogr D Biol Crystallogr (2005) 0.83

The nature of actinomycin D binding to d(AACCAXYG) sequence motifs. Nucleic Acids Res (2004) 0.82

Interaction of porphyrin with G-quadruplex structures. Nucleosides Nucleotides Nucleic Acids (2005) 0.77

Influence of substituent modifications on DNA binding energetics of acridine-based anticancer agents. Biochemistry (2003) 1.24

Extending nature's leads: the anticancer agent ellipticine. Curr Med Chem Anticancer Agents (2004) 1.11

Synthesis of the ABC ring system of azaspiracid. 1. Effect of D ring truncation on bis-spirocyclization. Org Lett (2002) 1.05

Interactions between the etoposide derivative F14512 and human type II topoisomerases: implications for the C4 spermine moiety in promoting enzyme-mediated DNA cleavage. Biochemistry (2011) 1.03

Synthesis of the ABC ring system of Azaspiracid. 2. A systematic study into the effect of C(16) and C(17) substitution on bis-spirocyclization. Org Lett (2002) 1.03

Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance. Biochemistry (2011) 1.01

Substituents on etoposide that interact with human topoisomerase IIalpha in the binary enzyme-drug complex: contributions to etoposide binding and activity. Biochemistry (2008) 0.99

Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion. APMIS (2012) 0.98

Topoisomerase II - drug interaction domains: identification of substituents on etoposide that interact with the enzyme. Biochemistry (2007) 0.98

Amsacrine as a topoisomerase II poison: importance of drug-DNA interactions. Biochemistry (2012) 0.90

Antiviral and anticancer optimization studies of the DNA-binding marine natural product aaptamine. Chem Biol Drug Des (2008) 0.84

Influence of the amino substituents in the interaction of ethidium bromide with DNA. Biophys J (2004) 0.84

Contributions of the D-Ring to the activity of etoposide against human topoisomerase IIα: potential interactions with DNA in the ternary enzyme--drug--DNA complex. Biochemistry (2011) 0.78